Showing results (1341-1350 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|September 7, 2017
Definitions and statistical properties of master protocols for personalized medicine in oncologyLindsay A Renfro, Sumithra J MandrekarJournal of Biopharmaceutical Statistics|February 9, 2018
Optimal dose selection accounting for patient subpopulations in a randomized Phase II trial to maximize the success probability of a subsequent Phase III trialFumihiro Takahashi, Satoshi MoritaJournal of Biopharmaceutical Statistics|March 16, 2018
Multiplicity-Adjusted Confidence Limits in Risk Assessment with Quantal Response DataLucy KernsJournal of Biopharmaceutical Statistics|March 20, 2018
Determining sample size for a binary diagnostic test in the presence of verification biasGuogen Shan, Hua Zhang, Tao JiangJournal of Biopharmaceutical Statistics|March 28, 2018
Approximate confidence intervals for the likelihood ratios of a binary diagnostic test in the presence of partial disease verificationM A Montero-Alonso, J A Roldán-NofuentesJournal of Biopharmaceutical Statistics|July 9, 2008
Using adaptive tests for the analysis of repeated measurementsT W O'GormanJournal of Biopharmaceutical Statistics|July 9, 2008
Generalizability in nongaussian longitudinal clinical trial data based on generalized linear mixed modelsTony Vangeneugden, Geert Molenberghs, Annouschka Laenen, et al.Journal of Biopharmaceutical Statistics|July 9, 2008
A safety monitoring procedure for a clinical drug development program, with application to the assessment of a novel COX-2 inhibitorKim Bolland, John Whitehead, Mary OldhamJournal of Biopharmaceutical Statistics|November 21, 2007
Optimal designs for estimating the interesting part of a dose-effect curveFrank Miller, Olivier Guilbaud, Holger DetteJournal of Biopharmaceutical Statistics|November 21, 2007
Statistical analysis for two-stage seamless design with different study endpointsShein-Chung Chow, Qingshu Lu, Siu-Keung TsePageof 216